Milagros González‐Rivera

564 citations
9 papers · 131 indexed · h-index 6

Milagros González‐Rivera

9 papers receiving 130 citations

Peers

Milagros González‐Rivera
Comparison fields: 5 of 32
  • Infectious Diseases 84
  • Epidemiology 71
  • Cancer Research 18
  • Oncology 26
  • Surgery 38
Replace Fatih Çelmeli with:
Fatih Çelmeli Türkiye
Han-Po Shih Taiwan
Lucille M. Rich United States
Ewa Kępka Poland
Tony Leclerc France
Audrey S.M. Teo Singapore
Naveen Nunna United States
Céline Baulard France
Prasad Taur India
Adi Ovadia Israel
Milagros González‐Rivera relative to Fatih Çelmeli Türkiye Fatih Çelmeli's profile →
Citations per field
00.5×4.5×
Fatih Çelmeli · 1×
Citations per year

Countries citing papers authored by Milagros González‐Rivera

Since Specialization
Citations

This map shows the geographic impact of Milagros González‐Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milagros González‐Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milagros González‐Rivera more than expected).

Fields of papers citing papers by Milagros González‐Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milagros González‐Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milagros González‐Rivera. The network helps show where Milagros González‐Rivera may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Milagros González‐Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Milagros González‐Rivera Line = papers co-authored together Milagros González‐Rivera links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20208
2 20166
3 201622
4 20155
5 20153
6 20142
7 201218
8 201139
9 200928

About Milagros González‐Rivera

Milagros González‐Rivera is a scholar working on Cancer Research, Hematology and Pharmaceutical Science, having authored 9 papers that have together received 131 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers), Cancer Cells and Metastasis (2 papers), Infectious Diseases and Tuberculosis (1 paper), Estrogen and related hormone effects (1 paper), BRCA gene mutations in cancer (1 paper) and Infectious Diseases and Mycology (1 paper). The work is most often cited by research in Infectious Diseases (84 citations), Epidemiology (71 citations) and Cancer Research (18 citations). Milagros González‐Rivera has collaborated with scholars based in Spain, United States and Peru. Frequent co-authors include Emilio Bouza, Pilar Escribano, Sandra Recio, Jesús Guinea, Teresa Peláez, Darı́o Garcı́a de Viedma, Miguel Martínez‐Lirola, Marta Herránz, María Alonso and Antoni C. Picornell. Their work appears in journals such as Journal of Clinical Microbiology, Clinical & Translational Oncology, Breast Cancer Research and Treatment, Antimicrobial Agents and Chemotherapy and Experimental Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026